Literature DB >> 21484635

[The early postnatal weight gain as a predictor of retinopathy of prematurity].

S Flückiger1, H U Bucher, A Hellström, C Lövqist, V Sturm, S J Arri.   

Abstract

BACKGROUND: Premature infants are often stressed by the current retinopathy of prematurity (ROP) screening procedure. Additionally, only < 10 % of the screened infants will develop a ROP stadium requiring laser therapy. Therefore the present screening strategy is unsatisfactory. Furthermore, the current guidelines do not take into account postnatal factors. A new method considering postnatal factors is the weight, insulin-like growth factor, neonatal ROP (WINROP) algorithm. This approach is based on the early postnatal weight gain. The aim of this study was to assign the WINROP-algorithm to a preterm population in Switzerland and to analyze its ability for prediction. PATIENTS AND METHODS: In this retrospective study, all preterm infants with a gestational age (GA) < 32 weeks and/or a birth weight (BW) ≤ 1500 g taken care of in the Department of Neonatology at the University Hospital Zurich from January 2003 to December 2008 were included. The weekly postnatal weight gain was analyzed by means of the modified WINROP-algorithm.
RESULTS: Altogether 376 preterm infants were analyzed. In 58 infants a "high-risk" alarm was released, thereof eight preterms developed a severe ROP and four of them needed laser therapy.
CONCLUSIONS: The high predictive value of the WINROP-algorithm was confirmed in our population of Swiss preterms. This instrument has the potential to simplify the current ROP screening procedure. Accordingly, the amount of ophthalmoscopies could be reduced significantly. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21484635     DOI: 10.1055/s-0031-1273217

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  9 in total

Review 1.  Retinopathy of prematurity.

Authors:  Ann Hellström; Lois E H Smith; Olaf Dammann
Journal:  Lancet       Date:  2013-06-17       Impact factor: 79.321

Review 2.  Educational paper: Retinopathy of prematurity.

Authors:  Ingele Casteels; Catherine Cassiman; Joachim Van Calster; Karel Allegaert
Journal:  Eur J Pediatr       Date:  2011-11-04       Impact factor: 3.183

3.  A predictive score for retinopathy of prematurity in very low birth weight preterm infants.

Authors:  G U Eckert; J B Fortes Filho; M Maia; R S Procianoy
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

4.  Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

Authors:  Anna-Lena Hård; Lois E Smith; Ann Hellström
Journal:  Semin Fetal Neonatal Med       Date:  2013-02-18       Impact factor: 3.926

Review 5.  The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.

Authors:  Lois E Smith; Anna-Lena Hard; Ann Hellström
Journal:  Clin Perinatol       Date:  2013-06       Impact factor: 3.430

6.  [Pathogenesis of retinopathy of prematurity].

Authors:  A Stahl; W A Lagrèze; H T Agostini
Journal:  Ophthalmologe       Date:  2012-12       Impact factor: 1.059

7.  The Use of Postnatal Weight Gain Algorithms to Predict Severe or Type 1 Retinopathy of Prematurity: A Systematic Review and Meta-analysis.

Authors:  Sam Athikarisamy; Saumil Desai; Sanjay Patole; Shripada Rao; Karen Simmer; Geoffrey C Lam
Journal:  JAMA Netw Open       Date:  2021-11-01

8.  Prediction of Retinopathy of Prematurity Using the WINROP (Weight, IGF-1, Neonatal Retinopathy of Prematurity) Algorithm in a South African Population.

Authors:  Samantha Jane Kesting; Firdose Lambey Nakwa
Journal:  Front Pediatr       Date:  2022-03-23       Impact factor: 3.418

9.  WINROP identifies severe retinopathy of prematurity at an early stage in a nation-based cohort of extremely preterm infants.

Authors:  Pia Lundgren; Elisabeth Stoltz Sjöström; Magnus Domellöf; Karin Källen; Gerd Holmström; Anna-Lena Hård; Lois E Smith; Chatarina Löfqvist; Ann Hellström
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.